CACT deficiency is characterized by a wide spectrum of clinical manifestations including hypoketotic hypoglycemia, hyperammonemia, liver dysfunction, cardiomyopathy, severe neurologic impairment and progressive myopathy (8). Here, SLC25A20 is linked to Hyperammonemia.